日本語 
Pharma
Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life Science, bringing extensive experience in the pharmaceutical industry, healthcare consulting and commercial strategy to the role. Suzuki has…
Ken Suzuki Joins Accenture as Principle Director for Life Sciences
Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…
Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…
Zealand Pharma and Generate Biomedicines Partner on AI-Designed Metabolic Disease Treatments
Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…
Zeal Launches MEDSCOPE for OTC Pharma Data Analysis
ZEAL, a DX company inside the Avant Group has introduced "MEDSCOPE," a…
SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy
SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…
ARIA Cybersecurity Deploys AZT PROTECT at Pharmaceutical Manufacturer
ARIA Cybersecurity, a business of CSPi, has announced a second deployment of…
Pharming Reports Positive Phase II Data for Leniolisib
Pharming Group announced data from a Phase II clinical trial that assessed…
Four Japanese Researchers Win Lasker Awards for Medical Innovation
I feel that four Japanese researchers have earned the 2026 Lasker Awards…
Ken Suzuki Joins Accenture as Principle Director for Life Sciences
Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…
Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…
Zealand Pharma and Generate Biomedicines Partner on AI-Designed Metabolic Disease Treatments
Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…
Zeal Launches MEDSCOPE for OTC Pharma Data Analysis
ZEAL, a DX company inside the Avant Group has introduced "MEDSCOPE," a…
SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy
SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…
ARIA Cybersecurity Deploys AZT PROTECT at Pharmaceutical Manufacturer
ARIA Cybersecurity, a business of CSPi, has announced a second deployment of…
Pharming Reports Positive Phase II Data for Leniolisib
Pharming Group announced data from a Phase II clinical trial that assessed…
Four Japanese Researchers Win Lasker Awards for Medical Innovation
I feel that four Japanese researchers have earned the 2026 Lasker Awards…
English